Vaccines could offer hope - but who to vaccinate, and against what, has no clear answer yet. Read IMI Executive Director Dr Pierre Meulien’s perspective on what is needed to tackle antimicrobial resistance.
Expansion at Val de Reuil reinforces the company's position as a global leader in seasonal flu vaccines
Ruxandra Draghia-Akli, deputy director general for research, in surprise move to US pharma group in June
The unique forum convening public and private sector leaders for networking, intelligence and debates on research and innovation.
These updates are republished press releases and communications from members of the Science|Business Network
Tweets by scibus